Company Monitoring Page for Roche

latest headlines for company on cafepharma

PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides
CP Wire
Fri, 07/20/18 - 11:29 am
Tags:
PureTech, Roche, drug development, antisense
Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices
Endpoints
Fri, 07/20/18 - 09:47 am
Tags:
Roche, Merck, Pfizer, Novartis, drug pricing, Donald Trump
Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
Fierce Pharma
Thu, 07/19/18 - 11:14 am
Tags:
Roche, immuno-oncology, Tecentriw, Merck, Keytruda, non-small cell lung cancer
Roche’s antiviral hits flu targets in PhIII trial
Pharma Times
Tue, 07/17/18 - 10:06 am
Tags:
Roche, baloxavir marboxil, antivirals, Flu, Shionogi
Many Drugmakers Ignore Trump—and Raise Prices Anyway
Bloomberg
Sun, 07/15/18 - 12:52 pm
Tags:
drug pricing, Donald Trump, Pfizer, Celgene, Roche, Novo Nordisk
Pharmas call off price hikes after California law forces new warnings: report
Fierce Pharma
Wed, 07/11/18 - 11:15 pm
Tags:
drug pricing, California, Novo Nordisk, Roche, Novartis, Gilead Sciences
3 Best Biotech Acquisitions of 2018 (So Far)
Motley Fool
Thu, 07/5/18 - 09:57 am
Tags:
M&A, biotech, Celgene, Juno Therapeutics, Novartis, AveXis, Roche, Foundation Medicine
FDA Limits the Use of Tecentriq and Keytruda
RAPS.org
Wed, 07/4/18 - 11:25 am
Tags:
FDA, Roche, Merck, Tecentriq, Keytruda, metastatic urothelial cancer
Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival
Endpoints
Mon, 07/2/18 - 09:37 am
Tags:
Roche, Tecentriq, Genentech, triple negative breast cancer, Celgene, Abraxane
The first single-dose flu drug nod could be FDA’s Christmas present for Roche
Fierce Pharma
Tue, 06/26/18 - 10:10 pm
Tags:
Roche, Shionogi, Xofluza, Flu, FDA
With latest data, has Roche's Tecentriq found a blockbuster lung cancer niche?
Fierce Pharma
Mon, 06/25/18 - 12:39 pm
Tags:
Roche, Tecentriq, clinical trials, small cell lung cancer
Tesaro stock rockets as rumours of Roche takeover abound
Pharmaforum
Fri, 06/22/18 - 10:21 pm
Tags:
Tesaro, Roche, M&A
FDA limits first-line bladder cancer labels for Keytruda, Tecentriq
Biopharma Dive
Fri, 06/22/18 - 12:13 pm
Tags:
FDA, Merck, Keytruda, Roche, Tecentriq, bladder cancer
Finding Cancer Patients Is the Pharma Industry’s Unlikely Challenge
Bloomberg
Wed, 06/20/18 - 11:44 am
Tags:
patients, cancer, Bayer, Roche, diagnostics
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
Xconomy
Tue, 06/19/18 - 10:50 am
Tags:
Roche, Foundation Medicine, M&A
Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs
Endpoints
Tue, 06/12/18 - 10:31 pm
Tags:
Roche, Pharma CEOs, Severin Schwan, R&D
AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
Endpoints
Mon, 06/11/18 - 09:17 am
Tags:
AbbVie, Roche, Venclexta, Rituxan, CLL, chronic lymphocytic leukemia
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study
Fierce Pharma
Wed, 06/6/18 - 09:32 pm
Tags:
Roche, MS, multiple sclerosis, Ocrevus, FDA, vaccines
ASCO18: Who were the big winners and losers?
Biopharma Dive
Wed, 06/6/18 - 04:06 pm
Tags:
ASCO 2018, Merck, Loxo Oncology, Bluebird Bio, Celgene, Roche, Nektar
Roche scrambles to boost Herceptin supply in China after insurance OK triggers shortage
Fierce Pharma
Wed, 06/6/18 - 09:33 am
Tags:
Roche, Herceptin, China

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.